We consent to the reference to our firm under the caption "Experts" in the Registration Statement (Form S-4 No. 333-291678) and related proxy
statement/prospectus of BioCryst Pharmaceuticals, Inc. and to the incorporation by reference therein of our report dated March 11, 2025, with respect to the consolidated financial statements of Astria Therapeutics, Inc.
included
in Astria Therapeutics, Inc.’s Annual Report (Form 10-K) for the year ended December 31, 2024, filed with the Securities and Exchange Commission.